Is Mounjaro Insulin? The Short Answer and What You Need to Know

Insulin is a hormone that regulates blood sugar by helping cells absorb glucose. Mounjaro (tirzepatide) does not do this in the same way, and it is not classified as insulin in any form — not short-acting, not long-acting, and not a basal insulin analogue.

So what is Mounjaro?

Tirzepatide is a synthetic peptide — a lab-made molecule that mimics two naturally occurring gut hormones: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). Because it acts on both receptors, it is described as a dual GIP/GLP-1 receptor agonist. You can read a fuller breakdown on our Mounjaro explained page, or explore the broader how Mounjaro works guide for the mechanism in more detail.

Is Mounjaro a steroid or a hormone?

No, it is not a steroid. It is a peptide medicine that mimics hormones, but it is not itself a hormone or a steroid in the clinical sense. It is also not a placebo — tirzepatide is a prescription-only medicine that has been through rigorous regulatory review before being approved for use.

Is Mounjaro a diabetes medication?

Tirzepatide was originally developed in the context of type 2 diabetes research, and Mounjaro is licensed for use in adults with type 2 diabetes in a number of countries. It is also licensed for weight management in eligible adults. Whether it is the right medicine for a particular person — and for which indication — is a decision made by their prescriber, not something to determine from general content. If you are curious about how Mounjaro compares to semaglutide-based medicines, see our page on whether Mounjaro is semaglutide.

Is Mounjaro safe, and is it bad for you?

Like all prescription medicines, Mounjaro carries potential risks alongside its intended effects, and it is subject to additional monitoring — you should report any side effects to your healthcare professional and to your national reporting scheme (such as the UK's Yellow Card scheme). For a more thorough look at the evidence, see our pages on Mounjaro safety and whether Mounjaro is bad for you. Any question about whether it is suitable for you personally belongs with your prescriber or doctor — they know your full medical history.

How is Mounjaro administered?

Mounjaro is given as a once-weekly subcutaneous injection using a pre-filled pen device. It is not taken by mouth, and it is not an intravenous or intramuscular injection. Your prescriber or the patient information leaflet supplied with your pen will guide you on the specifics of how to use it correctly.

Because Mounjaro is a weekly injection rather than a daily pill, keeping an accurate log of each dose matters more than many people expect — it is easy to lose track of which pen you are on, when you last injected, and how your body has responded week to week.

GLP Trackr's dose and injection logging lets you record every shot — the date, time, and dose strength — so there is always a clear record to refer back to. Alongside that, the side-effect tracker lets you note how you have been feeling after each dose, which can surface useful patterns over time and give you something concrete to bring to your next prescriber appointment rather than relying on memory.

If you are on Mounjaro and want to understand your own data more clearly — how your weight, energy, and appetite are shifting as your treatment progresses — the app's insights bring those threads together in one place. You can also use the Mounjaro dosing schedule page alongside the app's reminders to stay on top of your weekly routine.

GLP Trackr is a tracking app, not a medical service — it does not give clinical advice, and any questions about your dose, your suitability for treatment, or symptoms that concern you should go to your prescriber or doctor promptly.

Ready to keep a clearer record of your journey? GLP Trackr is free to try for 7 days — available on the App Store and Google Play.